Hsi‐Chin Wu
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 6
- Cancer, Lipids, and Metabolism 5
-
- Prostate Cancer Treatment and Research 15
- Prostate Cancer Diagnosis and Treatment 8
- Renal cell carcinoma treatment 5
- Molecular Medicine top 10%
- Biomaterials top 10%
- Urology top 5%
-
- Bladder and Urothelial Cancer Treatments 6
-
- Peptidase Inhibition and Analysis 4
-
- Renal and related cancers 4
- Co-authors
- Martin GleaveSen PathakLeland W. K. ChungTzu‐Wei WangJui‐Sheng SunLeland W.K. ChungHao‐Ming HsiaoAndrew C. von Eschenbach
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Hsi‐Chin Wu
57 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 243
- Pulmonary and Respiratory Medicine 460
- Molecular Medicine 67
- Biomaterials 163
- Urology 63
Countries citing papers authored by Hsi‐Chin Wu
This map shows the geographic impact of Hsi‐Chin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsi‐Chin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsi‐Chin Wu more than expected).
Fields of papers citing papers by Hsi‐Chin Wu
This network shows the impact of papers produced by Hsi‐Chin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsi‐Chin Wu. The network helps show where Hsi‐Chin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hsi‐Chin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 5 | |
| 9 | 2019 | 48 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 9 | |
| 12 | 2018 | 8 | |
| 13 | 2016 | 8 | |
| 14 | 2016 | 4 | |
| 15 | The Change of Student Perception toward PBL in a Medical School with a hybrid-PBL Preclinical Curriculum in Taiwan | 2012 | 2 |
| 16 | 2012 | 1 | |
| 17 | Design of PBL Cases in Bioethical Education Spanning across General and Professional Education | 2011 | 1 |
| 18 | 2009 | 42 | |
| 19 | A Ureteral Diverticulum Mimicking Pelvic Cyst | 2002 | 0 |
| 20 | 1994 | 425 |
About Hsi‐Chin Wu
Hsi‐Chin Wu is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Protease and Inhibitor Mechanisms (6 papers), Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (5 papers), Cancer, Lipids, and Metabolism (5 papers), Peptidase Inhibition and Analysis (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Cancer Research (243 citations), Pulmonary and Respiratory Medicine (460 citations) and Molecular Medicine (67 citations). Hsi‐Chin Wu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Martin Gleave, Sen Pathak, Leland W. K. Chung, Tzu‐Wei Wang, Jui‐Sheng Sun, Leland W.K. Chung, Hao‐Ming Hsiao, Andrew C. von Eschenbach, Jer‐Tsong Hsieh and Guo‐Chung Dong.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.